Advertisement
 
 
Log in
Welcome Guest



User:
Pass:
Anonymous: 
Advertisement
Donate To Depression Forums
Latest Forum Discussions
on: Friday, 04 July 2008 18:41
on: Friday, 04 July 2008 18:16
on: Friday, 04 July 2008 17:59
on: Friday, 04 July 2008 17:53
on: Friday, 04 July 2008 17:44
Search

Advanced Search

Member Testimonials
hello just want to say hello,and tell you all that this site have helpt me many times.
(from elin in norway)
HOPELINE 1-800-SUICIDE
hopeline.com
Depression & Mental Health FAQs
US Centers for Disease Control and Prevention (CDC) estimated 40 million
Americans living today will suffer from major depressive illness during their lives.

Seasonal affective disorder is major depression that appears in the fall or winter and goes away in spring, thought to be caused by lack of sunlight.



Postpartum depression occurs within four weeks of a women giving childbirth. Most new mothers suffer from some form of the �baby blues.� Postpartum depression, by contrast, is major depression, thought to be triggered by changes in hormonal flows associated with childbirth.

Catatonic depression is a rare form of major depression characterized by (at least two): Stupor, excessive motor activity, extreme negativism, peculiarities in voluntary movement, and repetition of other people's words or actions. - mcmanweb.com



Psychotic depression is a rare form of depression characterized by delusions or hallucinations, such as believing you are someone you are not and hearing voices.


According to the National Institute of Mental Health, approximately 18.8 million American adults, or about 9.5 percent of the US population age 18 and older in a given year, have a depressive disorder.
Depression is a chronic illness that exacts a significant toll on America's health and productivity.  It affects more than 21 million American children and adults annually and is the leading cause of disability in the United States for individuals ages 15 to 44.


Lost productive time among U.S. workers due to depression is estimated to be in excess of $31 billion per year.  Depression frequently co-occurs with a variety of medical illnesses such as heart disease, cancer, and chronic pain and is associated with poorer health status and prognosis.  It is also the principal cause of the 30,000 suicides in the U.S. each year.  In 2004, suicide was the 11th leading cause of death in the United States, third among individuals 15-24.


According to the World Health Organization, depression is presently on track to becoming the world's second-most disabling disease (after heart disease) by the year 2020.

Depression is responsible for some $87 billion a year in lost productivity in the US (a conservative estimate), and according to Bank One, is responsible for most lost work days in its employees after pregnancy and childbirth.

Additionally, one million people worldwide die by their own hand, most as a result of a mood disorder. Finally, the linkage between depression and a host of physical illnesses makes it arguably the world's greatest killer.

Research presented at the 56th Annual Conference of the Canadian Psychiatric Association shows a marked link between bipolar disorder and migraines.

The odds of migraine in persons with bipolar disorder were 40% higher than the general population.

Data obtained from 36,984 people aged 15 and over, who screened positive for manic or depressive episodes with migraine, were compared against those who screened positive for mania but who didn�t suffer from migraines.

Amongst males, 14.9% of those with manic episodes were also diagnosed with migraines compared with 5.8% of the general population. Amongst females, 34.7% had both migraines and bipolar disorder compared with 14.7% who only had migraines.unquote.gif

While the research was skewed towards persons who were already diagnosed with bipolar disorders, what does it mean for people who suffer from migraines but who may have an undiagnosed bipolar disorder?



Migraines and headaches aren�t fully understood but the manifestations are very real and debilitating for their sufferers:

Throbbing pain
Nausea
Heightened sensitivity to light or sound
Seeing dots, wavy lines, flashing lights, or blind spots
Difficulty with speech, sensation, or movement

 


An estimated 2.1 million American adolescents have experienced major depression within the last year, according to a new comprehensive government study.  Researchers surveyed more than 67,000 young people ages 12 to 17 and found that one in 12 had suffered from serious depression in the previous year.Nearly 13 percent of girls had struggled with depression, compared to less than 5 percent of boys. Odds of depression increased with age -- just 4 percent of 12-year-olds experienced depression but that climbed to 11 percent for older teens.

Our DF Members
www.flickr.com
This is a Flickr badge showing photos in a set called DF Potpourii. Make your own badge here.

Atypical Antidepressants

By Lindsay
Atypical Antidepressants

Atypical antidepressants may be prescribed when SSRIs or TCAs have not worked. Atypical antidepressants include bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL), duloxetine (Cymbalta), maprotiline (Ludiomil), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and venlafaxine (Effexor).

How do atypical antidepressants work? Each of these drugs inhibit uptake of the various neurotransmitters in the brain.

Who should not use these medications?

* Individuals with a prior allergic reaction to any atypical antidepressant


* Individuals with seizure disorders (Do not use bupropion and maprotiline.)


* Individuals taking MAOIs (Do not use duloxetine, maprotiline, and venlafaxine.)


* Other contraindications include the following:

o Bupropion: Individuals with bulimia or anorexia nervosa, or those in the process of withdrawal from alcohol or sedatives should not take bupropion.


o Duloxetine: Individuals with uncontrolled narrow-angle glaucoma should not take duloxetine.


o Maprotiline, mirtazapine, nefazodone, and trazodone: Individuals who have experienced a recent heart attack should not take these medications.


o Nefazodone: Individuals should not take nefazodone if they have liver impairment or are currently using cisapride (Propulsid), pimozide (Orap), carbamazepine (Tegretol), or triazolam (Halcion).

Use

* Atypical antidepressants are administered orally.


* Mirtazapine (Remeron SolTab) is a tablet that dissolves when placed in the mouth instead of swallowing with water.


* Some atypical antidepressants are available as sustained-release tablets or capsules and should only be swallowed whole (do not crush, divide, or chew).


* Abrupt discontinuation of some atypical antidepressants, such as duloxetine, may cause withdrawal-like symptoms such as agitation, anxiety, confusion, dizziness, headache, and insomnia. Ask a doctor or pharmacist if the medication dose should be gradually tapered down to avoid these symptoms.

Children: Safety and efficacy of duloxetine, bupropion, maprotiline, mirtazapine, nefazodone, and trazodone have not been established in children younger than 18 years.

Drug or food interactions: Tell the doctor what medications are currently being taken because many drugs interact with atypical antidepressants. Do not take any nonprescription or herbal medications without first consulting the doctor or pharmacist. The following are examples of interactions, but they do not represent a complete list.

* Bupropion

o Bupropion may increase the blood levels and/or risk of toxicity of the following drugs:

+ Alcohol or other drugs that depress the central nervous system such as drugs taken for insomnia


+ SSRIs


+ TCAs


+ Beta blockers such as propranolol (Inderal)


+ Antiarrhythmic drugs such as flecainide (Tambocor) or propafenone (Rythmol)


+ Warfarin (Coumadin)

o The following drugs may increase bupropion blood levels or toxicity:

+ Other drugs that increase seizure risk


+ Amantadine (Symmetrel)


+ Levodopa (Sinemet)


+ Carbamazepine (Tegretol)


+ MAOIs


+ Ritonavir (Norvir)

* Duloxetine

o Duloxetine may increase the blood levels and/or risk of toxicity of the following drugs:

+ Alcohol or other drugs that depress the central nervous system such as drugs taken for insomnia


+ Antiarrhythmic drugs such as flecainide (Tambocor) or propafenone (Rythmol)


+ Phenothiazines such as thioridazine (Mellaril)


+ TCAs


+ MAOIs


+ Warfarin (Coumadin)

o The following drugs may increase duloxetine blood levels or toxicity:

+ Fluvoxamine (Luvox)


+ Fluoxetine (Prozac)


+ Paroxetine (Paxil)


+ Quinidine (Cardioquin, Quinaglute)


+ Quinolone antibiotics such as ciprofloxacin (Cipro) and levofloxacin (Levaquin)

* Maprotiline and mirtazapine

o Maprotiline may increase the blood levels and/or risk of toxicity of the following drugs:

+ Alcohol or other drugs that depress the central nervous system such as drugs taken for insomnia


+ Drugs with similar side effects such as TCAs or antihistamines (Benadryl)

o The following drugs may increase maprotiline blood levels or toxicity:

+ Thyroid medication may add to the risk of increased heart rate and abnormal rhythm.


+ Phenothiazines and benzodiazepines (such as Valium) increase risk for seizures.

* Nefazodone

o Nefazodone may increase the blood levels and/or risk of toxicity of the following drugs:

+ Alcohol or other drugs that depress the central nervous system such as drugs taken for insomnia


+ Buspirone (Buspar)


+ Carbamazepine (Tegretol)


+ Cisapride (Propulsid)


+ Cyclosporine (Neoral, Sandimmune)


+ Digoxin (Lanoxin)


+ Pimozide (Orap)


+ Thioridazine (Mellaril)


+ Triazolam (Halcion)


+ St. John’s wort


+ SSRIs


+ TCAs


+ Drugs that may cause abnormal heart rhythms (check with the doctor or pharmacist)


+ Drugs indicated to treat high cholesterol such as simvastatin (Zocor) or atorvastatin (Lipitor)

o The following drugs may increase nefazodone blood levels or toxicity:

+ Buspirone (Buspar)


+ Sibutramine (Meridia)


+ Sumatriptan (Imitrex) or other similar drugs for migraine headache

* Trazodone

o Trazodone may alter the blood levels and/or risk of toxicity of the following drugs:


+ Alcohol or other drugs that depress the central nervous system such as drugs taken for insomnia


+ Clonidine (Catapres) (enhances blood pressure lowering effect)


+ Digoxin (Lanoxin)


+ MAOIs


+ Phenytoin or fosphenytoin (Dilantin, Cerebyx)


+ Warfarin (Coumadin)

o The following drugs may increase trazodone blood levels or toxicity:

+ Antifungal agents such as itraconazole (Sporanox) or ketoconazole (Nizoral)


+ Carbamazepine (Tegretol)


+ Phenothiazines such as thioridazine (Mellaril)


+ Ritonavir (Norvir)


+ SSRIs, sibutramine (Meridia), sumatriptan (Imitrex), trazodone (Desyrel), venlafaxine (Effexor), and St. John’s wort (These medications may increase the risk for serotonin syndrome—symptoms include hypertension, fever, muscle tremor, or confusion.)


+ Drugs that may cause abnormal heart rhythms (check with the doctor or pharmacist)

* Venlafaxine

o Venlafaxine may alter the blood levels and/or risk of toxicity of the following drugs:

+ Clozapine


+ Desipramine


+ Haloperidol (Haldol)


+ Indinavir


+ SSRIs, sibutramine (Meridia), sumatriptan (Imitrex), trazodone (Desyrel), and St. John’s wort (These medications may increase the risk for serotonin syndrome—symptoms include hypertension, fever, muscle tremor, or confusion.)


+ Warfarin

o The following drugs may increase venlafaxine blood levels or toxicity:

+ Cimetidine (Tagamet)

* MAOIs


* SSRIs, nefazodone (Serzone), St. John’s wort, and venlafaxine (These medications may increase the risk for serotonin syndrome—symptoms include hypertension, fever, muscle tremor, or confusion.)

Side Effects: This is NOT a complete list of side effects reported with atypical antidepressants. The doctor, health care provider, or pharmacist can discuss a more complete list of side effects.

*

Manic episodes in persons with bipolar disorder (If not combined with a mood-stabilizing drug, atypical antidepressants may induce manic episodes in individuals with bipolar disorder.)
*

Seizures (Atypical antidepressants may lower the threshold for seizures; that is, seizures may occur more easily. Caution is advised for individuals prone to seizures or those who have a history of seizures.)
*

Drowsiness (Caution is advised when operating machinery, driving, or performing other tasks that require alertness.)
*

Bupropion
o Contains the same active ingredient found in Zyban, which is used as an aid in smoking cessation treatment (Do not use bupropion with Zyban or other medications containing bupropion.)


o More likely to cause seizures than other antidepressants, especially with doses above 450 mg/day (Seizures are also more likely in patients who have bulimia or anorexia nervosa and are treated with bupropion.)


o Caution in narrow-angle glaucoma


o Caution in slow gastric emptying (often present in diabetes)

* Maprotiline and mirtazapine

o May increase appetite and cause weight gain


o May decrease white blood cell count (The doctor will monitor this throughout the therapy.)


o May cause urinary retention, blurred vision, heart rhythm abnormalities, dizziness, or constipation


o Caution in heart disease and abnormal heart rhythms

* Nefazodone

o May cause liver impairment (Contact the doctor immediately if dark urine, anorexia, stomach or abdominal pain, or yellowing of the skin or eyes occurs.)


o Caution in heart disease and abnormal heart rhythms


o Lightheadedness or fainting when standing up from a sitting or lying position (Stand up gradually from lying down or sitting positions.)

* Trazodone

o Caution in heart disease and abnormal heart rhythms

* Venlafaxine

o May cause sustained increases in blood pressure


o May cause weight loss


o May cause anxiety and insomnia


o Decreased dose required for individuals with kidney or severe liver impairment

Comments

This Month In Pictures
Members Online
97 Users Online:
88  Guests
2  Anonymous
7  Visible:
Isabeau, Florry, Ashen, mets1983, lalahop, bear, darkshadow,
Medical News
Depression News From Medical News Today
Latest Depression News From Medical News Today.

Depression Ups Risk Of Complications Following Heart Attack
People who suffer from severe depression following a heart attack might be more likely to experience cardiac complications while hospitalized, according to a new study. "There is good evidence that if a person has depression after a heart attack, they are more likely to die from cardiac causes in the following months and years," said lead author Jeff Huffman, M.D., assistant professor of psychiatry at Harvard Medical School.

St. Jude Medical Announces First Patient Implants In Clinical Study Evaluating Deep Brain Stimulation For Depression
St. Jude Medical, Inc. (NYSE:STJ) announced the first patient implants in a clinical study that is investigating whether deep brain stimulation (DBS) therapy will help people who suffer from major depressive disorder, a severe form of depression. The patients, a 59-year-old woman and a 42-year-old man, were implanted at Alexian Brothers Behavioral Health Hospital in Chicago, with the St. Jude Medical Libra® Deep Brain Stimulation System, an investigational device.




ADHD News From Medical News Today
Latest ADHD News From Medical News Today.

CONCERTA® Now Available For Patients With ADHD Ages 6 To 65 In USA
ADHD is the most common emotional, cognitive and behavioral disorder treated in children1, and according to the National Institute of Mental Health (NIMH), between 30 percent and 70 percent of children with ADHD continue to exhibit symptoms in the adult years 2.

NIMH Funds Pitt Researchers To Find Best Treatments For Children With Autism And ADHD Symptoms
Researchers at the University of Pittsburgh and the Western Psychiatric Institute and Clinic of UPMC have received $3 million from the National Institute of Mental Health to conduct a national study of the treatment of attention deficit hyperactivity disorder (ADHD) in children with autism spectrum disorders.




Anxiety / Stress News From Medical News Today
Latest Anxiety / Stress News From Medical News Today.

Relaxation Response Can Influence Expression Of Stress-Related Genes
How could a single, nonpharmacological intervention help patients deal with disorders ranging from high blood pressure, to pain syndromes, to infertility, to rheumatoid arthritis? That question may have been answered by a study finding that eliciting the relaxation response - a physiologic state of deep rest - influences the activation patterns of genes associated with the body's response to stress.

Yoga And Meditation Change Gene Response To Stress
Research from the US suggests that mind body techniques like yoga and meditation that put the body in a state of deep rest known as the relaxation response, are capable of changing how genes behave in response to stress.




Bipolar News From Medical News Today
Latest Bipolar News From Medical News Today.

Relapse Time Prolonged In Clinically Stable Patients With Bipolar I Disorder Treated With Quetiapine As Adjunct Therapy To Mood Stabilisers
AstraZeneca announced the online publication of long-term SEROQUEL® (quetiapine fumarate) clinical trial data in the Journal of Affective Disorders. Results show that SEROQUEL in combination with lithium or divalproex significantly increased the time to recurrence of any mood event in patients with bipolar I disorder compared with lithium or divalproex alone.

Repligen Announces Plans To Initiate A Phase 2b Trial For RG2417 In Bipolar Disorder
Repligen Corporation (Nasdaq: RGEN) announced that based on feedback from the Food and Drug Administration, the Company plans to initiate a Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar disorder later this year. This will be a multi-center, parallel arm placebo-controlled, clinical trial in which approximately 150 patients with bipolar disorder will receive either RG2417 or a placebo twice a day for eight-weeks.




Mental Health News From Medical News Today
Latest Mental Health News From Medical News Today.

Death Of Psychiatric Patient At New York Hospital Underscores Mental Health Care Crisis
The reported death of a woman at King's County Hospital in Brooklyn, N.Y., illustrates the dire need for more public services for individuals with mental illness, according to the American Psychiatric Association. According to news reports, a woman who was suffering from agitation and psychosis, was kept waiting in the emergency room for almost 24 hours because the hospital reportedly did not have a bed available for psychiatric patients.

Mental Health Treatment: It's Commonly Accepted Yet Not So Easy To Obtain Or Understand
Seeing a psychologist or other mental health professional isn't an unusual thing; in fact it's relatively common. Nearly three in ten U.S. adults (29%) report that they have received treatment or therapy from a psychologist or other mental health professional. The survey also found that younger adults are more open to seeking mental health treatment than those over 50 and that many adults are not discouraged from seeking treatment because of stigma or fear of others finding out.




Psychology / Psychiatry News From Medical News Today
Latest Psychology / Psychiatry News From Medical News Today.

Death Of Psychiatric Patient At New York Hospital Underscores Mental Health Care Crisis
The reported death of a woman at King's County Hospital in Brooklyn, N.Y., illustrates the dire need for more public services for individuals with mental illness, according to the American Psychiatric Association. According to news reports, a woman who was suffering from agitation and psychosis, was kept waiting in the emergency room for almost 24 hours because the hospital reportedly did not have a bed available for psychiatric patients.

Mental Health Treatment: It's Commonly Accepted Yet Not So Easy To Obtain Or Understand
Seeing a psychologist or other mental health professional isn't an unusual thing; in fact it's relatively common. Nearly three in ten U.S. adults (29%) report that they have received treatment or therapy from a psychologist or other mental health professional. The survey also found that younger adults are more open to seeking mental health treatment than those over 50 and that many adults are not discouraged from seeking treatment because of stigma or fear of others finding out.




Schizophrenia News From Medical News Today
Latest Schizophrenia News From Medical News Today.

FDA Approves First Generic Risperidone To Treat Psychiatric Conditions
The U.S. Food and Drug Administration approved the first generic versions of Risperdal (risperidone) tablets. Risperdal is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder, and other psychiatric conditions.

NARSAD Appoints Lou Innamorato As Acting President
NARSAD's Board of Directors announced that its President and Chief Executive Officer Geoff Birkett has resigned to pursue other opportunities. During Mr. Birkett's tenure, he ran the organization with a new energy and focus. The Chief Financial Officer, Lou Innamorato, will serve as Acting President as the Board begins the search for a new President and Chief Executive Officer. NARSAD is the world's leading charity dedicated to mental health research.




Sleep / Sleep Disorders / Insomnia News From Medical News Today
Latest Sleep / Sleep Disorders / Insomnia News From Medical News Today.

Difficulty Sleeping Increases As Women Progress Through Menopause According To Study By Rush University Medical Center
Difficulty falling asleep and staying asleep increase as women go through menopause according to research by Rush University Medical Center. Waking up earlier than planned also increases through late perimenopause but decreases when women become postmenopausal. The study is published in the July 1 issue of the journal SLEEP.

Plants And Mammals Respond To Light In Similar Way
A new report published in the open-access journal PLoS Biology examines the effect that light has on humans and animals. Most of us are familiar with how light affects the growth and development of plants (phototropism, for example, describes how plants grow towards light), but researcher Nathalie Hoang and colleagues set out to explore light's impact on humans and mammals.




Andertoon
Vote for DF
Rate this Site for Psych Central:
A Potpourri of Mental Health Articles
Mental Health Parity News
Suicide Prevention Llifeline
suicidepreventionlifeline.org
Amazon Books

The Instinct to HealThe Instinct to Heal

David Servan-Schre...

New $10.85

Living Well with Depress...Living Well with Depression and Bipo...

John Mcmanamy

New $10.17

The Instinct to HealThe Instinct to Heal

David Servan-Schre...

The Food-Mood SolutionThe Food-Mood Solution

Jack Challem, Melv...

New $10.17

SOS Help for EmotionsSOS Help for Emotions

Lynn Clark

New $11.20
Our Soldiers & Veterans
edclogo


eatingdisorderscoalition.org
Depression & Mental Health FAQs 2
What is Clinical Depression?

Clinical depression can affect your body, mood, thoughts, and behavior. It can change your eating habits, how you feel and think about things, your ability to work and study, and how you interact with people.

Clinical depression is not a passing mood, a sign of personal weakness or a condition that can be willed away. Clinically depressed people cannot "pull themselves together" and get better.

Depression can be successfully treated by a mental health professional or certain health care providers. With the right treatment, 80 percent of those who seek help get better. And many people begin to feel better in just a few weeks.

Depression a Big Factor in Poor Health
World Health Organization Finds Depression Often Goes Untreated
By Salynn Boyles
WebMD Medical News
Reviewed by Louise Chang, MD

Sept. 6, 2007 -- Depression has a greater impact on overall health than arthritis, diabetes, angina, and asthma, but it all too often goes unrecognized and untreated, a report from the World Health Organization (WHO) suggests.
more...Depression a Big Factor in Poor Health

For Additional Information About Depression Write To:
The National Institute of Mental Health (NIMH)
6001 Executive Boulevard, Room 8184, MSC 9663
Bethesda, MD 20892-9663
 

For free brochures on depression and its treatment call:  1-800-421-4211.
or visit: http://www.nimh.nih.gov
Link To Us
Please use the image below and the code provided to link back to us